Clinical Trial Update: The Role of SGLT2i in Management of Moderate AS [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating SGLT2 inhibitors in moderate aortic valve stenosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: University of East Anglia | Conditions: Moderate Aortic Valve Stenosis | Phase 2, Phase 3 | Status: COMPLETED